nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—vascular cancer	0.46	0.544	CtDrD
Sunitinib—kidney cancer—vascular cancer	0.385	0.456	CtDrD
Sunitinib—STK10—renal vein—vascular cancer	0.00848	0.177	CbGeAlD
Sunitinib—ERN1—blood vessel—vascular cancer	0.0026	0.0543	CbGeAlD
Sunitinib—MYLK—blood vessel—vascular cancer	0.00164	0.0343	CbGeAlD
Sunitinib—MYLK3—cardiac atrium—vascular cancer	0.00125	0.0261	CbGeAlD
Sunitinib—FLT4—blood vessel—vascular cancer	0.00118	0.0246	CbGeAlD
Sunitinib—PRKAA2—cardiac atrium—vascular cancer	0.00105	0.022	CbGeAlD
Sunitinib—JAK2—blood vessel—vascular cancer	0.000983	0.0205	CbGeAlD
Sunitinib—CDK14—cardiac atrium—vascular cancer	0.000919	0.0192	CbGeAlD
Sunitinib—FLT1—blood vessel—vascular cancer	0.000916	0.0191	CbGeAlD
Sunitinib—LATS2—cardiac atrium—vascular cancer	0.000906	0.0189	CbGeAlD
Sunitinib—RPS6KA5—cardiac atrium—vascular cancer	0.000894	0.0187	CbGeAlD
Sunitinib—RIOK1—cardiac atrium—vascular cancer	0.000797	0.0167	CbGeAlD
Sunitinib—KDR—blood vessel—vascular cancer	0.000774	0.0162	CbGeAlD
Sunitinib—ICK—cardiac atrium—vascular cancer	0.000767	0.016	CbGeAlD
Sunitinib—NUAK1—cardiac atrium—vascular cancer	0.000741	0.0155	CbGeAlD
Sunitinib—INSR—cardiac atrium—vascular cancer	0.000735	0.0154	CbGeAlD
Sunitinib—OXSR1—cardiac atrium—vascular cancer	0.000735	0.0154	CbGeAlD
Sunitinib—SNRK—cardiac atrium—vascular cancer	0.000735	0.0154	CbGeAlD
Sunitinib—RPS6KA2—cardiac atrium—vascular cancer	0.000723	0.0151	CbGeAlD
Sunitinib—STK38—cardiac atrium—vascular cancer	0.000723	0.0151	CbGeAlD
Sunitinib—PKN1—cardiac atrium—vascular cancer	0.000712	0.0149	CbGeAlD
Sunitinib—CSNK1G2—cardiac atrium—vascular cancer	0.000712	0.0149	CbGeAlD
Sunitinib—PRPF4—cardiac atrium—vascular cancer	0.000702	0.0147	CbGeAlD
Sunitinib—PRPF4B—cardiac atrium—vascular cancer	0.000692	0.0145	CbGeAlD
Sunitinib—KIT—blood vessel—vascular cancer	0.000686	0.0143	CbGeAlD
Sunitinib—STK39—cardiac atrium—vascular cancer	0.000682	0.0143	CbGeAlD
Sunitinib—CSNK2A1—cardiac atrium—vascular cancer	0.000673	0.0141	CbGeAlD
Sunitinib—PDGFRB—blood vessel—vascular cancer	0.00067	0.014	CbGeAlD
Sunitinib—MYLK—cardiac atrium—vascular cancer	0.000665	0.0139	CbGeAlD
Sunitinib—DAPK2—cardiac atrium—vascular cancer	0.00063	0.0132	CbGeAlD
Sunitinib—HIPK3—cardiac atrium—vascular cancer	0.000617	0.0129	CbGeAlD
Sunitinib—RIOK2—cardiac atrium—vascular cancer	0.00061	0.0127	CbGeAlD
Sunitinib—DAPK3—cardiac atrium—vascular cancer	0.000592	0.0124	CbGeAlD
Sunitinib—CLK2—cardiac atrium—vascular cancer	0.000587	0.0123	CbGeAlD
Sunitinib—MAP4K4—cardiac atrium—vascular cancer	0.000532	0.0111	CbGeAlD
Sunitinib—MAP3K12—cardiac atrium—vascular cancer	0.000524	0.011	CbGeAlD
Sunitinib—RPS6KA3—cardiac atrium—vascular cancer	0.000517	0.0108	CbGeAlD
Sunitinib—CSNK1A1—cardiac atrium—vascular cancer	0.000507	0.0106	CbGeAlD
Sunitinib—CLK1—cardiac atrium—vascular cancer	0.000504	0.0105	CbGeAlD
Sunitinib—FGFR1—cardiac atrium—vascular cancer	0.00047	0.00981	CbGeAlD
Sunitinib—ULK3—cardiac atrium—vascular cancer	0.000452	0.00945	CbGeAlD
Sunitinib—MAP2K2—cardiac atrium—vascular cancer	0.000452	0.00945	CbGeAlD
Sunitinib—MAP3K7—cardiac atrium—vascular cancer	0.000445	0.00929	CbGeAlD
Sunitinib—TBK1—cardiac atrium—vascular cancer	0.00044	0.00919	CbGeAlD
Sunitinib—TYK2—cardiac atrium—vascular cancer	0.000437	0.00912	CbGeAlD
Sunitinib—RPS6KB1—cardiac atrium—vascular cancer	0.000423	0.00884	CbGeAlD
Sunitinib—AXL—cardiac atrium—vascular cancer	0.000419	0.00875	CbGeAlD
Sunitinib—SLK—cardiac atrium—vascular cancer	0.000403	0.00842	CbGeAlD
Sunitinib—JAK2—cardiac atrium—vascular cancer	0.000397	0.0083	CbGeAlD
Sunitinib—FYN—cardiac atrium—vascular cancer	0.000392	0.00819	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—vascular cancer	0.000383	0.008	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—vascular cancer	0.000383	0.008	CbGeAlD
Sunitinib—FLT1—cardiac atrium—vascular cancer	0.00037	0.00773	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—vascular cancer	0.000366	0.00765	CbGeAlD
Sunitinib—YES1—cardiac atrium—vascular cancer	0.000354	0.00739	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—vascular cancer	0.000349	0.00729	CbGeAlD
Sunitinib—KDR—cardiac atrium—vascular cancer	0.000313	0.00654	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—vascular cancer	0.000313	0.00654	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—vascular cancer	0.000305	0.00638	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—vascular cancer	0.000271	0.00566	CbGeAlD
Sunitinib—ABCB1—blood vessel—vascular cancer	0.000186	0.00388	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—vascular cancer	0.000171	0.00358	CbGeAlD
Sunitinib—MAP3K3—Immune System—CD34—vascular cancer	5.73e-05	0.000537	CbGpPWpGaD
Sunitinib—JAK2—Downstream signaling of activated FGFR—TSC2—vascular cancer	5.72e-05	0.000536	CbGpPWpGaD
Sunitinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	5.69e-05	0.000534	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—TSC2—vascular cancer	5.66e-05	0.00053	CbGpPWpGaD
Sunitinib—FYN—Downstream signal transduction—TSC2—vascular cancer	5.65e-05	0.00053	CbGpPWpGaD
Sunitinib—MAP2K1—Insulin Signaling—TSC2—vascular cancer	5.65e-05	0.000529	CbGpPWpGaD
Sunitinib—KIT—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	5.64e-05	0.000529	CbGpPWpGaD
Sunitinib—JAK2—Signaling by ERBB4—TSC2—vascular cancer	5.62e-05	0.000527	CbGpPWpGaD
Sunitinib—FYN—Signaling by FGFR—TSC2—vascular cancer	5.62e-05	0.000527	CbGpPWpGaD
Sunitinib—MAP2K1—Downstream signal transduction—TSC2—vascular cancer	5.62e-05	0.000527	CbGpPWpGaD
Sunitinib—FGFR1—B Cell Activation—TSC2—vascular cancer	5.6e-05	0.000525	CbGpPWpGaD
Sunitinib—FYN—Signaling by ERBB2—TSC2—vascular cancer	5.6e-05	0.000524	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by FGFR—TSC2—vascular cancer	5.59e-05	0.000524	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—CD34—vascular cancer	5.59e-05	0.000524	CbGpPWpGaD
Sunitinib—PDGFRA—B Cell Activation—TSC2—vascular cancer	5.58e-05	0.000523	CbGpPWpGaD
Sunitinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	5.57e-05	0.000522	CbGpPWpGaD
Sunitinib—MAP2K2—DAP12 interactions—TSC2—vascular cancer	5.57e-05	0.000522	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by FGFR in disease—TSC2—vascular cancer	5.57e-05	0.000522	CbGpPWpGaD
Sunitinib—FYN—DAP12 signaling—TSC2—vascular cancer	5.57e-05	0.000522	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by ERBB2—TSC2—vascular cancer	5.57e-05	0.000522	CbGpPWpGaD
Sunitinib—MAP2K1—DAP12 signaling—TSC2—vascular cancer	5.54e-05	0.000519	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by EGFR—TSC2—vascular cancer	5.52e-05	0.000517	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—CD34—vascular cancer	5.49e-05	0.000515	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—CD34—vascular cancer	5.49e-05	0.000515	CbGpPWpGaD
Sunitinib—FYN—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	5.49e-05	0.000514	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by EGFR in Cancer—TSC2—vascular cancer	5.47e-05	0.000513	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by PDGF—TSC2—vascular cancer	5.45e-05	0.00051	CbGpPWpGaD
Sunitinib—RPS6KA5—Innate Immune System—TSC2—vascular cancer	5.44e-05	0.00051	CbGpPWpGaD
Sunitinib—PDGFRB—DAP12 interactions—TSC2—vascular cancer	5.43e-05	0.000509	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by FGFR in disease—TSC2—vascular cancer	5.43e-05	0.000509	CbGpPWpGaD
Sunitinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	5.43e-05	0.000509	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by EGFR—TSC2—vascular cancer	5.39e-05	0.000505	CbGpPWpGaD
Sunitinib—RPS6KA2—Innate Immune System—TSC2—vascular cancer	5.38e-05	0.000505	CbGpPWpGaD
Sunitinib—JAK2—Downstream signal transduction—TSC2—vascular cancer	5.37e-05	0.000503	CbGpPWpGaD
Sunitinib—FGFR1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	5.36e-05	0.000502	CbGpPWpGaD
Sunitinib—JAK2—Signaling by FGFR—TSC2—vascular cancer	5.35e-05	0.000501	CbGpPWpGaD
Sunitinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	5.34e-05	0.000501	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by EGFR in Cancer—TSC2—vascular cancer	5.34e-05	0.0005	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—WWTR1—vascular cancer	5.34e-05	0.0005	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—CD34—vascular cancer	5.33e-05	0.000499	CbGpPWpGaD
Sunitinib—JAK2—Signaling by ERBB2—TSC2—vascular cancer	5.32e-05	0.000498	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by PDGF—TSC2—vascular cancer	5.32e-05	0.000498	CbGpPWpGaD
Sunitinib—JAK2—DAP12 signaling—TSC2—vascular cancer	5.29e-05	0.000496	CbGpPWpGaD
Sunitinib—FYN—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	5.24e-05	0.000491	CbGpPWpGaD
Sunitinib—FYN—Signaling by FGFR in disease—TSC2—vascular cancer	5.24e-05	0.000491	CbGpPWpGaD
Sunitinib—FYN—DAP12 interactions—TSC2—vascular cancer	5.24e-05	0.000491	CbGpPWpGaD
Sunitinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	5.21e-05	0.000488	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by FGFR in disease—TSC2—vascular cancer	5.21e-05	0.000488	CbGpPWpGaD
Sunitinib—MAP2K1—DAP12 interactions—TSC2—vascular cancer	5.21e-05	0.000488	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—CD34—vascular cancer	5.21e-05	0.000488	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—CD34—vascular cancer	5.2e-05	0.000487	CbGpPWpGaD
Sunitinib—FYN—Signaling by EGFR—TSC2—vascular cancer	5.19e-05	0.000487	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CD34—vascular cancer	5.18e-05	0.000486	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by EGFR—TSC2—vascular cancer	5.16e-05	0.000484	CbGpPWpGaD
Sunitinib—FYN—Signaling by EGFR in Cancer—TSC2—vascular cancer	5.15e-05	0.000482	CbGpPWpGaD
Sunitinib—FYN—Signaling by PDGF—TSC2—vascular cancer	5.12e-05	0.00048	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by EGFR in Cancer—TSC2—vascular cancer	5.12e-05	0.00048	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by PDGF—TSC2—vascular cancer	5.1e-05	0.000478	CbGpPWpGaD
Sunitinib—PDGFRB—B Cell Activation—TSC2—vascular cancer	5.03e-05	0.000471	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—WWTR1—vascular cancer	5.01e-05	0.000469	CbGpPWpGaD
Sunitinib—JAK2—Signaling by FGFR in disease—TSC2—vascular cancer	4.98e-05	0.000467	CbGpPWpGaD
Sunitinib—JAK2—DAP12 interactions—TSC2—vascular cancer	4.98e-05	0.000467	CbGpPWpGaD
Sunitinib—JAK2—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	4.98e-05	0.000467	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—WWTR1—vascular cancer	4.96e-05	0.000465	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—HBA1—vascular cancer	4.96e-05	0.000465	CbGpPWpGaD
Sunitinib—JAK2—Signaling by EGFR—TSC2—vascular cancer	4.94e-05	0.000463	CbGpPWpGaD
Sunitinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.93e-05	0.000462	CbGpPWpGaD
Sunitinib—JAK2—Signaling by EGFR in Cancer—TSC2—vascular cancer	4.89e-05	0.000458	CbGpPWpGaD
Sunitinib—JAK2—Signaling by PDGF—TSC2—vascular cancer	4.87e-05	0.000456	CbGpPWpGaD
Sunitinib—FYN—B Cell Activation—TSC2—vascular cancer	4.85e-05	0.000454	CbGpPWpGaD
Sunitinib—RPS6KA1—Innate Immune System—TSC2—vascular cancer	4.84e-05	0.000453	CbGpPWpGaD
Sunitinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.81e-05	0.000451	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CD34—vascular cancer	4.75e-05	0.000445	CbGpPWpGaD
Sunitinib—TYK2—Disease—WWTR1—vascular cancer	4.69e-05	0.00044	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—CD34—vascular cancer	4.68e-05	0.000439	CbGpPWpGaD
Sunitinib—PHKG1—Disease—TSC2—vascular cancer	4.64e-05	0.000435	CbGpPWpGaD
Sunitinib—FYN—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.64e-05	0.000435	CbGpPWpGaD
Sunitinib—BLK—Immune System—CD34—vascular cancer	4.63e-05	0.000434	CbGpPWpGaD
Sunitinib—FGFR2—Disease—WWTR1—vascular cancer	4.63e-05	0.000434	CbGpPWpGaD
Sunitinib—FGR—Immune System—CD34—vascular cancer	4.62e-05	0.000433	CbGpPWpGaD
Sunitinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.61e-05	0.000433	CbGpPWpGaD
Sunitinib—IRAK1—Signaling by NGF—TSC2—vascular cancer	4.61e-05	0.000432	CbGpPWpGaD
Sunitinib—KIT—Disease—WWTR1—vascular cancer	4.55e-05	0.000427	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—WWTR1—vascular cancer	4.55e-05	0.000426	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—CD34—vascular cancer	4.51e-05	0.000423	CbGpPWpGaD
Sunitinib—TYK2—Signaling by NGF—TSC2—vascular cancer	4.48e-05	0.000419	CbGpPWpGaD
Sunitinib—TBK1—Innate Immune System—TSC2—vascular cancer	4.44e-05	0.000417	CbGpPWpGaD
Sunitinib—FGFR2—Signaling by NGF—TSC2—vascular cancer	4.42e-05	0.000414	CbGpPWpGaD
Sunitinib—JAK2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.41e-05	0.000413	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—WWTR1—vascular cancer	4.38e-05	0.00041	CbGpPWpGaD
Sunitinib—CSNK1G2—Disease—TSC2—vascular cancer	4.36e-05	0.000409	CbGpPWpGaD
Sunitinib—GRK1—Disease—TSC2—vascular cancer	4.36e-05	0.000409	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—WWTR1—vascular cancer	4.35e-05	0.000408	CbGpPWpGaD
Sunitinib—KIT—Signaling by NGF—TSC2—vascular cancer	4.34e-05	0.000407	CbGpPWpGaD
Sunitinib—FGFR1—Disease—WWTR1—vascular cancer	4.32e-05	0.000405	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—WWTR1—vascular cancer	4.31e-05	0.000404	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—TSC2—vascular cancer	4.29e-05	0.000402	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—WWTR1—vascular cancer	4.22e-05	0.000395	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—WWTR1—vascular cancer	4.22e-05	0.000395	CbGpPWpGaD
Sunitinib—FGFR1—Signaling by NGF—TSC2—vascular cancer	4.12e-05	0.000386	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—WWTR1—vascular cancer	4.11e-05	0.000385	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling by NGF—TSC2—vascular cancer	4.11e-05	0.000385	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—WWTR1—vascular cancer	3.98e-05	0.000373	CbGpPWpGaD
Sunitinib—IRAK4—Innate Immune System—TSC2—vascular cancer	3.96e-05	0.000371	CbGpPWpGaD
Sunitinib—PHKG2—Disease—TSC2—vascular cancer	3.95e-05	0.00037	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—WWTR1—vascular cancer	3.88e-05	0.000364	CbGpPWpGaD
Sunitinib—RPS6KA3—Innate Immune System—TSC2—vascular cancer	3.85e-05	0.000361	CbGpPWpGaD
Sunitinib—ITK—Immune System—TSC2—vascular cancer	3.81e-05	0.000357	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by NGF—TSC2—vascular cancer	3.79e-05	0.000356	CbGpPWpGaD
Sunitinib—FYN—Disease—WWTR1—vascular cancer	3.74e-05	0.000351	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD34—vascular cancer	3.73e-05	0.000349	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—WWTR1—vascular cancer	3.72e-05	0.000349	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling by NGF—TSC2—vascular cancer	3.7e-05	0.000347	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—TSC2—vascular cancer	3.65e-05	0.000342	CbGpPWpGaD
Sunitinib—PAK3—Immune System—TSC2—vascular cancer	3.63e-05	0.000341	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—WWTR1—vascular cancer	3.57e-05	0.000334	CbGpPWpGaD
Sunitinib—FYN—Signaling by NGF—TSC2—vascular cancer	3.57e-05	0.000334	CbGpPWpGaD
Sunitinib—JAK2—Disease—WWTR1—vascular cancer	3.56e-05	0.000333	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by NGF—TSC2—vascular cancer	3.55e-05	0.000333	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD34—vascular cancer	3.54e-05	0.000331	CbGpPWpGaD
Sunitinib—CSNK2A1—Disease—TSC2—vascular cancer	3.46e-05	0.000324	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—TSC2—vascular cancer	3.44e-05	0.000322	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD34—vascular cancer	3.43e-05	0.000322	CbGpPWpGaD
Sunitinib—JAK2—Signaling by NGF—TSC2—vascular cancer	3.39e-05	0.000318	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD34—vascular cancer	3.39e-05	0.000318	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—WWTR1—vascular cancer	3.38e-05	0.000317	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD34—vascular cancer	3.33e-05	0.000312	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD34—vascular cancer	3.33e-05	0.000312	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—TSC2—vascular cancer	3.31e-05	0.00031	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—WWTR1—vascular cancer	3.29e-05	0.000308	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—WWTR1—vascular cancer	3.25e-05	0.000304	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—WWTR1—vascular cancer	3.19e-05	0.000299	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—WWTR1—vascular cancer	3.19e-05	0.000299	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—TSC2—vascular cancer	3.17e-05	0.000297	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD34—vascular cancer	3.16e-05	0.000296	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD34—vascular cancer	3.15e-05	0.000295	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—TSC2—vascular cancer	3.14e-05	0.000294	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—TSC2—vascular cancer	3.05e-05	0.000286	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—TSC2—vascular cancer	3.05e-05	0.000286	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—WWTR1—vascular cancer	3.02e-05	0.000283	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—WWTR1—vascular cancer	3.02e-05	0.000283	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD34—vascular cancer	2.91e-05	0.000273	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—TSC2—vascular cancer	2.9e-05	0.000271	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD34—vascular cancer	2.84e-05	0.000266	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—TSC2—vascular cancer	2.82e-05	0.000264	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—WWTR1—vascular cancer	2.79e-05	0.000261	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—TSC2—vascular cancer	2.77e-05	0.00026	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—TSC2—vascular cancer	2.76e-05	0.000259	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD34—vascular cancer	2.74e-05	0.000257	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD34—vascular cancer	2.72e-05	0.000255	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—WWTR1—vascular cancer	2.72e-05	0.000255	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—TSC2—vascular cancer	2.66e-05	0.00025	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—TSC2—vascular cancer	2.65e-05	0.000248	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—TSC2—vascular cancer	2.63e-05	0.000246	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—WWTR1—vascular cancer	2.62e-05	0.000246	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—WWTR1—vascular cancer	2.61e-05	0.000244	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD34—vascular cancer	2.6e-05	0.000244	CbGpPWpGaD
Sunitinib—TBK1—Immune System—TSC2—vascular cancer	2.59e-05	0.000243	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—TSC2—vascular cancer	2.55e-05	0.000239	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—TSC2—vascular cancer	2.55e-05	0.000239	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—TSC2—vascular cancer	2.54e-05	0.000238	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—WWTR1—vascular cancer	2.53e-05	0.000237	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—TSC2—vascular cancer	2.52e-05	0.000236	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—WWTR1—vascular cancer	2.5e-05	0.000235	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—WWTR1—vascular cancer	2.49e-05	0.000233	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—TSC2—vascular cancer	2.48e-05	0.000233	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—TSC2—vascular cancer	2.48e-05	0.000232	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—TSC2—vascular cancer	2.48e-05	0.000232	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TSC2—vascular cancer	2.42e-05	0.000227	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TSC2—vascular cancer	2.42e-05	0.000227	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—TSC2—vascular cancer	2.42e-05	0.000227	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—TSC2—vascular cancer	2.38e-05	0.000223	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—TSC2—vascular cancer	2.38e-05	0.000223	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—TSC2—vascular cancer	2.35e-05	0.00022	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TSC2—vascular cancer	2.35e-05	0.00022	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—TSC2—vascular cancer	2.34e-05	0.00022	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—TSC2—vascular cancer	2.31e-05	0.000216	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—TSC2—vascular cancer	2.26e-05	0.000211	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—TSC2—vascular cancer	2.25e-05	0.000211	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—TSC2—vascular cancer	2.24e-05	0.00021	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—TSC2—vascular cancer	2.23e-05	0.000209	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TSC2—vascular cancer	2.17e-05	0.000203	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—TSC2—vascular cancer	2.16e-05	0.000203	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—TSC2—vascular cancer	2.11e-05	0.000198	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—TSC2—vascular cancer	2.06e-05	0.000193	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TSC2—vascular cancer	2.05e-05	0.000192	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—TSC2—vascular cancer	2.04e-05	0.000191	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TSC2—vascular cancer	2.03e-05	0.00019	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—TSC2—vascular cancer	2.03e-05	0.00019	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—TSC2—vascular cancer	2.02e-05	0.00019	CbGpPWpGaD
Sunitinib—BLK—Immune System—TSC2—vascular cancer	2.01e-05	0.000188	CbGpPWpGaD
Sunitinib—FGR—Immune System—TSC2—vascular cancer	2e-05	0.000188	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—TSC2—vascular cancer	1.95e-05	0.000183	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—TSC2—vascular cancer	1.93e-05	0.000181	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TSC2—vascular cancer	1.93e-05	0.000181	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TSC2—vascular cancer	1.82e-05	0.000171	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—WWTR1—vascular cancer	1.81e-05	0.00017	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TSC2—vascular cancer	1.81e-05	0.000169	CbGpPWpGaD
Sunitinib—YES1—Immune System—TSC2—vascular cancer	1.61e-05	0.000151	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TSC2—vascular cancer	1.56e-05	0.000146	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—TSC2—vascular cancer	1.53e-05	0.000144	CbGpPWpGaD
Sunitinib—TYK2—Immune System—TSC2—vascular cancer	1.49e-05	0.000139	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—TSC2—vascular cancer	1.47e-05	0.000138	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TSC2—vascular cancer	1.46e-05	0.000137	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TSC2—vascular cancer	1.45e-05	0.000136	CbGpPWpGaD
Sunitinib—KIT—Immune System—TSC2—vascular cancer	1.44e-05	0.000135	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—TSC2—vascular cancer	1.44e-05	0.000135	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—HBA1—vascular cancer	1.41e-05	0.000133	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—HBA1—vascular cancer	1.4e-05	0.000131	CbGpPWpGaD
Sunitinib—TYK2—Disease—TSC2—vascular cancer	1.37e-05	0.000129	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—TSC2—vascular cancer	1.37e-05	0.000128	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—WWTR1—vascular cancer	1.37e-05	0.000128	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—TSC2—vascular cancer	1.37e-05	0.000128	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TSC2—vascular cancer	1.36e-05	0.000127	CbGpPWpGaD
Sunitinib—KIT—Disease—TSC2—vascular cancer	1.33e-05	0.000125	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TSC2—vascular cancer	1.33e-05	0.000125	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TSC2—vascular cancer	1.28e-05	0.00012	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TSC2—vascular cancer	1.27e-05	0.000119	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TSC2—vascular cancer	1.26e-05	0.000118	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TSC2—vascular cancer	1.26e-05	0.000118	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—TSC2—vascular cancer	1.26e-05	0.000118	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TSC2—vascular cancer	1.23e-05	0.000116	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TSC2—vascular cancer	1.23e-05	0.000116	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—TSC2—vascular cancer	1.23e-05	0.000115	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TSC2—vascular cancer	1.2e-05	0.000113	CbGpPWpGaD
Sunitinib—FYN—Immune System—TSC2—vascular cancer	1.19e-05	0.000111	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—TSC2—vascular cancer	1.18e-05	0.000111	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TSC2—vascular cancer	1.16e-05	0.000109	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TSC2—vascular cancer	1.14e-05	0.000106	CbGpPWpGaD
Sunitinib—JAK2—Immune System—TSC2—vascular cancer	1.13e-05	0.000106	CbGpPWpGaD
Sunitinib—FYN—Disease—TSC2—vascular cancer	1.09e-05	0.000103	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TSC2—vascular cancer	1.09e-05	0.000102	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TSC2—vascular cancer	1.04e-05	9.79e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—TSC2—vascular cancer	1.04e-05	9.75e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—HBA1—vascular cancer	1.01e-05	9.5e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TSC2—vascular cancer	9.9e-06	9.28e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TSC2—vascular cancer	9.61e-06	9.01e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TSC2—vascular cancer	9.49e-06	8.9e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TSC2—vascular cancer	9.32e-06	8.74e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TSC2—vascular cancer	9.32e-06	8.74e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TSC2—vascular cancer	8.85e-06	8.29e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TSC2—vascular cancer	8.83e-06	8.27e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—WWTR1—vascular cancer	8.42e-06	7.89e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TSC2—vascular cancer	8.15e-06	7.64e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TSC2—vascular cancer	7.95e-06	7.45e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TSC2—vascular cancer	7.66e-06	7.18e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HBA1—vascular cancer	7.65e-06	7.17e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TSC2—vascular cancer	7.62e-06	7.14e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TSC2—vascular cancer	7.29e-06	6.83e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HBA1—vascular cancer	4.71e-06	4.42e-05	CbGpPWpGaD
